Stroke Diagnostic and Therapeutic

Stroke Diagnostic and Therapeutic Market to Exceed $ 65.6 Billion by 2030 The stroke diagnostic and therapeutic market is expected to exhibit a CAGR of 8% from 2021 to 2030 and is projected to reach US$ 65.6 Billion by 2030, according to a 2021 study by Precedence Research, the Canada based market insight company.

Share This Article

The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global stroke diagnostic and therapeutic market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global stroke diagnostic and therapeutic market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the stroke diagnostic and therapeutic industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Stroke is a brain attack, and when blood supply to the brain is diminished or halted, it occurs. Due to the inadequate supply of oxygen and nutrients to the brain, brain cells die in this state. It can happen to anybody at any moment and its manifestations are hemorrhagic, ischemic and ischemic transient assaults. Blockage of arteries linked to the brain is the main cause of ischemic stroke, while hemorrhagic stroke is caused by brain arteries bursting open or leaking blood. It leads to TIA stroke if blood flow is momentarily disrupted for a short amount of time. The fifth leading cause of adult disability and adult mortality in North America is stroke, according to data released by the National Stroke Association.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1226

Growth Factors:

Increasing number of patients at risk of increasing stroke across the globe is major factor driving growth of the global stroke diagnostics and therapeutic market. Increasing prevalence of high blood pressure among the population across the globe which is a key risk factor fuelling patients developing stroke at risk. For instance, according to the data published by American Heart Association in 2018, 103 million U.S. adults have high blood pressure and are increasing at major rate. Geriatric population is increasing now days in developed as well as emerging economies which are major factor of generating developing stroke at risk among individuals. Additionally, some of the major factors increasing risk of stroke are smoking, diabetes, high cholesterol, physical inactivity and obesity, carotid or other artery disease.

These factors are creating huge demand for the stroke diagnostics and therapeutic in turn which is driving growth of the global market. Increased healthcare expenditure is another factor anticipated to boost growth of the global market in the near future. Developed economies across the globe such as U.S., Canada, Germany, and U.K. are spending huge amount of money on healthcare each year. This is owing to increasing awareness among the individuals across the globe regarding better health outcomes, coupled with increasing per capita income tend to have a higher level of health expenditures per capita worldwide. Furthermore, health deteriorates and health-care spending is increasing owing to growing old age population across the globe which is in turn tends to support growth of the global stroke diagnostics and therapeutic market. Moreover, the private and public payer spending has also increased. The United States has a healthcare system that consists primarily of private providers and private insurers, but since healthcare has become a greater part of the economy, the government has received a higher share of healthcare funding. All these factors are supporting growth of the global market in the near future.

Report Highlights:

  • On the basis of type, diagnostics segment is estimated hold largest revenue share in the forecast period of time 2021-2030. Additionally, the therapeutics type is projected to fuel growth of the global industry in the near future.
  • On the basis of application, ischemic stroke segment accounted for the largest revenue with weighty share in 2020 as ischemic stroke is the most usual type of stroke which is caused by a blood clot that blocks a blood vessel in the brain. Hemorrhagic segment is predictable to grow at moderate CAGR during the forecast time-frame.
  • Medtronic plc. Foremost player in the global industry estimated for the remarkable share of the global market. The growth is accredited to various commercial strategies adopted by the company.

Regional Analysis:

The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America dominated the global market with a market share of more than 30%. The growth of the North American region is owing to increased number of stroke patient in the United States and Canada of the region. Further, rapidly increasing old age population in the North American countries is becoming major factor for the growth of the target industry in the region. Europe is another important region holding significant share owing to favorable government policies, increasing geriatric population in the countries of Europe. Moreover, increasing patient awareness and increasing health care expenditure are expected to propel growth of the target industry in the countries of Asia Pacific especially in the China, Japan, and India of the region.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global stroke diagnostic and therapeutic market are as follows:

  • Neural Analytics
  • Cordis Corporation
  • Cerebrotech Medical Systems, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc.
  • Boston Scientific Corporation
  • GE Healthcare
  • Medfield Diagnostics
  • Samsung Neurologica
  • NIRX
  • Gowerlabs
  • Siemens AG
  • Genentech Inc.
  • Merck & Co., Inc.
  • Hyperfine MRI
  • Stryker Corporation
  • Abbott Laboratories

Market Segmentation

By Type

  • Diagnostics
      • Magnetic Resonance Imaging (MRI)
      • Computed Tomography Scan (CT scan)
      • Electrocardiography
      • Carotid Ultrasound
      • Cerebral Angiography
      • Others
  • Therapeutics
      • Tissue Plasminogen Activator
      • Antiplatelet
      • Antihypertensive
      • Anticoagulant

By Application

  • Haemorrhagic Stroke
  • Ischemic Stroke

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global stroke diagnostic and therapeutic market. It examines trends and factors influencing demand for stroke diagnostic and therapeutic globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for stroke diagnostic and therapeutic across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on stroke diagnostic and therapeutic. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global stroke diagnostic and therapeutic market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for stroke diagnostic and therapeutic are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Stroke Diagnostic And Therapeutic Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Stroke Diagnostic And Therapeutic Market

5.1. Covid-19: stroke diagnostic and therapeutic Industry Impact
5.2. stroke diagnostic and therapeutic Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and stroke diagnostic and therapeutic Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for stroke diagnostic and Therapeutic Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Stroke Diagnostic And Therapeutic Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1.1. Increasing number of patients at risk of developing stroke
6.1.1.1.2. Increasing patient awareness
6.1.1.1.3. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost of treatment and unfavorable reimbursement scenario
6.1.3. Market Opportunities
6.1.3.1. Growing ongoing research & development in the healthcare sector technologies and emerging markets

Chapter 7. Global Stroke Diagnostic And Therapeutic Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. stroke diagnostic and Therapeutic Market Revenue by Market Players (2017 – 2020)
7.1.1.2. stroke diagnostic and Therapeutic Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Stroke Diagnostic And Therapeutic Market, By Type

8.1. stroke diagnostic and Therapeutic Market, by Type, 2017-2030
8.1.1. Diagnostic
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Therapeutics
8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Stroke Diagnostic And Therapeutic Market, By Application

9.1. stroke diagnostic and therapeutic Market, by Application, 2017-2030
9.1.1. Haemorrhagic Stroke
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ischemic Stroke
9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Stroke Diagnostic And Therapeutic Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Type (2017-2030)
10.1.2. Market Revenue Forecast by Application(2017-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2017-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2017-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2017-2030)
10.2.2. Market Revenue Forecast by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2017-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2017-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2017-2030)
10.3.2. Market Revenue Forecast by Application (2017-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2017-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2017-2030)
10.4.2. Market Revenue Forecast by Application (2017-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2017-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2017-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2017-2030)
10.5.2. Market Revenue Forecast by Application (2017-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2017-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2017-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2017-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2017-2030)

Chapter 11. Company Profiles

11.1. Boston Scientific Corporation
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. Medtronic plc
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. Cerebrotech Medical Systems, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Cordis Corporation
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. Neural Analytics
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Koninklijke Philips N.V.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Medfield Diagnostics
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. GE Healthcare
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. Samsung Neurologica
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies
11.10. Siemens AG
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2017-2020)
11.10.4. Recent Developments and Strategies
11.11. NIRX
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Product Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin (2017-2020)
11.11.4. Recent Developments and Strategies
11.12. Gowerlabs
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Product Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin (2017-2020)
11.12.4. Recent Developments and Strategies
11.13. Stryker Corporation
11.13.1. Company Overview, Business Information, Regional Presence
11.13.2. Product Portfolio Analysis
11.13.2.1. Product Details, Specification, Application
11.13.3. Revenue, Price, and Gross Margin (2017-2020)
11.13.4. Recent Developments and Strategies
11.14. Genentech Inc.
11.14.1. Company Overview, Business Information, Regional Presence
11.14.2. Product Portfolio Analysis
11.14.2.1. Product Details, Specification, Application
11.14.3. Revenue, Price, and Gross Margin (2017-2020)
11.14.4. Recent Developments and Strategies
11.15. Merck & Co., Inc.
11.15.1. Company Overview, Business Information, Regional Presence
11.15.2. Product Portfolio Analysis
11.15.2.1. Product Details, Specification, Application
11.15.3. Revenue, Price, and Gross Margin (2017-2020)
11.15.4. Recent Developments and Strategies
11.16. Hyperfine MRI
11.16.1. Company Overview, Business Information, Regional Presence
11.16.2. Product Portfolio Analysis
11.16.2.1. Product Details, Specification, Application
11.16.3. Revenue, Price, and Gross Margin (2017-2020)
11.16.4. Recent Developments and Strategies
11.17. Abbott Laboratories
11.17.1. Company Overview, Business Information, Regional Presence
11.17.2. Product Portfolio Analysis
11.17.2.1. Product Details, Specification, Application
11.17.3. Revenue, Price, and Gross Margin (2017-2020)
11.17.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1226

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →